GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Acquired by ST Germain D J Co. Inc.

ST Germain D J Co. Inc. increased its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 21.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,212 shares of the company’s stock after purchasing an additional 575 shares during the period. ST Germain D J Co. Inc.’s holdings in GE HealthCare Technologies were worth $251,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Wealth Enhancement Advisory Services LLC raised its stake in shares of GE HealthCare Technologies by 0.5% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 30,597 shares of the company’s stock worth $2,392,000 after purchasing an additional 146 shares during the last quarter. First Hawaiian Bank raised its position in GE HealthCare Technologies by 4.6% during the 4th quarter. First Hawaiian Bank now owns 30,011 shares of the company’s stock worth $2,346,000 after buying an additional 1,314 shares during the last quarter. Douglas Lane & Associates LLC raised its position in GE HealthCare Technologies by 4.4% during the 4th quarter. Douglas Lane & Associates LLC now owns 480,419 shares of the company’s stock worth $37,559,000 after buying an additional 20,415 shares during the last quarter. Park National Corp OH lifted its stake in shares of GE HealthCare Technologies by 6.0% in the 4th quarter. Park National Corp OH now owns 3,796 shares of the company’s stock worth $297,000 after acquiring an additional 216 shares during the period. Finally, Nordea Investment Management AB boosted its holdings in shares of GE HealthCare Technologies by 30.2% in the fourth quarter. Nordea Investment Management AB now owns 43,632 shares of the company’s stock valued at $3,429,000 after acquiring an additional 10,116 shares in the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, CEO Roland Rott sold 3,577 shares of the company’s stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the transaction, the chief executive officer now directly owns 24,298 shares in the company, valued at approximately $2,101,291.04. This represents a 12.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Trading Down 1.7 %

Shares of GEHC opened at $84.76 on Friday. GE HealthCare Technologies Inc. has a 1-year low of $71.31 and a 1-year high of $94.55. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. The firm has a 50 day simple moving average of $82.25 and a 200-day simple moving average of $84.13. The stock has a market cap of $38.72 billion, a price-to-earnings ratio of 23.29, a price-to-earnings-growth ratio of 2.90 and a beta of 1.11.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.06 by $0.08. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The business had revenue of $4.86 billion for the quarter, compared to the consensus estimate of $4.87 billion. During the same period in the prior year, the business earned $0.99 earnings per share. The business’s revenue was up .9% on a year-over-year basis. Equities analysts forecast that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.17%. The ex-dividend date of this dividend is Tuesday, January 14th. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s payout ratio is currently 3.85%.

Wall Street Analysts Forecast Growth

GEHC has been the subject of a number of recent analyst reports. UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and reduced their price objective for the company from $84.00 to $74.00 in a research report on Thursday, September 26th. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price target for the company from $95.00 to $103.00 in a report on Wednesday. Wells Fargo & Company upped their price objective on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. Evercore ISI raised their target price on GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. Finally, Stifel Nicolaus upped their price target on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a research note on Monday, September 30th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $96.00.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.